Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
MEDIROM Healthcare Technologies Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$5.09 |
52 Week High | US$7.40 |
52 Week Low | US$3.50 |
Beta | 0.036 |
1 Month Change | -6.40% |
3 Month Change | -15.18% |
1 Year Change | -10.64% |
3 Year Change | -46.83% |
5 Year Change | n/a |
Change since IPO | -66.32% |
Recent News & Updates
Shareholder Returns
MRM | US Consumer Services | US Market | |
---|---|---|---|
7D | -8.3% | -1.3% | 1.2% |
1Y | -10.6% | 6.0% | 20.5% |
Return vs Industry: MRM underperformed the US Consumer Services industry which returned 22.3% over the past year.
Return vs Market: MRM underperformed the US Market which returned 21.8% over the past year.
Price Volatility
MRM volatility | |
---|---|
MRM Average Weekly Movement | 5.5% |
Consumer Services Industry Average Movement | 8.1% |
Market Average Movement | 5.8% |
10% most volatile stocks in US Market | 15.5% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: MRM has not had significant price volatility in the past 3 months.
Volatility Over Time: MRM's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 708 | Kouji Eguchi | medirom.co.jp |
MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.
MEDIROM Healthcare Technologies Inc. Fundamentals Summary
MRM fundamental statistics | |
---|---|
Market cap | US$24.85m |
Earnings (TTM) | -US$156.37k |
Revenue (TTM) | US$44.89m |
0.6x
P/S Ratio-158.9x
P/E RatioIs MRM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MRM income statement (TTM) | |
---|---|
Revenue | JP¥7.05b |
Cost of Revenue | JP¥5.28b |
Gross Profit | JP¥1.77b |
Other Expenses | JP¥1.79b |
Earnings | -JP¥24.56m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -5.03 |
Gross Margin | 25.05% |
Net Profit Margin | -0.35% |
Debt/Equity Ratio | -288.7% |
How did MRM perform over the long term?
See historical performance and comparison